PharmaCyte Biotech Inc (PMCB)

[Alydyr]

SHAREHOLDER DILUTION at NVLX

The transactions I've highlighted below, reflect UNREGISTERED NVLX share issuances and/or conversions between $0.071 and $0.25 between Jan 21 and April 2014.

On January 21, 2014 NVLX issued 7 MILLION unregistered shares at $.071/share. Another 10 MILLION on February 28th for just .10/share.

There is some SERIOUS DILUTION going on here.

Don't take my word for it, see for yourself.....

From the recent NVLX Form 10-K......

Recent Issuance of Unregistered Securities

On January 21, 2014, the Company sold 7,000,000 shares of common stock to an accredited investor for total cash proceeds of $500,000.

On January 29, 2014, the Company sold 500,000 shares of common stock to an accredited investor for total cash proceeds of $50,000.

On February 4, 2014, the Company sold 100,000 shares of common stock to an accredited investor for total cash proceeds of $10,000.

On February 14, 2014, the Company sold 8,000,000 shares of common stock to Lincoln Park Capital Fund, LLC (“Lincoln Park”) for total cash proceeds of $2,000,000.

On February 18, 2014, the Company sold 1,000,000 shares of common stock to an accredited investor for total cash proceeds of $100,000.

On February 26, 2014, the Company sold 50,000 shares of common stock to an accredited investor for total cash proceeds of $5,000.

On February 28, 2014, the Company sold 10,000,000 shares of common stock to an accredited investor for total cash proceeds of $1,000,000.

On March 11, 2014, the Company sold 50,000 shares of common stock to an accredited investor for total cash proceeds of $5,000.

During February 2014, the Company converted outstanding Class A warrants into 15,204,600 shares of common stock for total cash proceeds of $1,140,345.

During March 2014, the Company converted outstanding Class A and Class B warrants into 4,045,000 shares of common stock for total cash proceeds of $359,175.

During April 2014, the Company converted outstanding Class B warrants into 528,000 shares of common stock for total cash proceeds of $63,360.

All shares were issued without registration under the Securities Act in reliance upon the exemption afforded by Section 4(2) of that Act based on the limited number of investors, the sophistication of the individuals involved and the use of restrictive legends on the shares certificates issued to prevent a public distribution of the relevant securities. No underwriters were involved in any of the foregoing issuances.